1VT

Viking Therapeutics Inc

Common Stock · EUR · F

1VT

Price

€26.388

+6.20%

Cap

€245.71B

Earnings

30d Trend

-8.7%

1VT
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

57% annualised over 90 days

BRAIN47 SIGNAL

0
MODERATE
Risk Level81
Quality37
Momentum56
Technical45
Fundamentals35

Raw weighted: 42×Macro 0.99 (1%)=42

RISK

81/100
90d Volatility
56.7%High
ATR %
4.6%High daily moves
Max Drawdown (1Y)
-45.1%Volatile

QUALITY

37/100
ROE (avg)
-56.3%*Negative
Piotroski F-Score
3/9Weak
Accruals
-11.3%Cash earnings

MOMENTUM

56/100
12-1M Momentum
+19.0%Strong uptrend
6-1M Momentum
-11.7%Negative
1M Return
-2.3%Stable
Relative Strength
+0.2% vs sectorIn-line

TECHNICAL

45/100
RSI (14)
51.2Neutral
Price vs SMA200
-2.7%Bearish trend
MACD
+0.14Bullish momentum
Bollinger Band
69%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.051Noisy/choppy

FUNDAMENTALS

35/100
Shareholder Yield
0.2%Low

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months51
3-12 months30
1-5+ years45

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate Viking Therapeutics Inc at 42/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is momentum at 56/100. I classify this as a income position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

-2.3%

3 MONTHS

-6.4%

12 MONTHS

+16.7%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Limited short-term thesis. Momentum (56) and Technical (45) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 57%. I classify this as an income position — the 17.0% yield combined with the dividend profile makes it suitable for income generation.

incomeScore: 42/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.